SYNLOGIC, INC. (SYBX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
20/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSYBX / S&P 14.92% / 15.20% |
LoseSYBX / S&P SYBX unavailable / 15.00% |
LoseSYBX / S&P -25.00% / 50.40% |
| 2026-Q10/3 |
LoseSYBX / S&P -45.54% / -4.33% |
LoseSYBX / S&P SYBX unavailable / 11.30% |
LoseSYBX / S&P -128.57% / 27.70% |
| 2025-Q40/3 |
LoseSYBX / S&P -32.85% / 2.65% |
LoseSYBX / S&P -100.00% / 9.00% |
LoseSYBX / S&P -95.85% / 13.40% |
| 2025-Q31/3 |
WinSYBX / S&P 31.34% / 8.12% |
LoseSYBX / S&P -100.00% / 4.61% |
LoseSYBX / S&P -87.74% / 13.45% |
| 2025-Q20/3 |
LoseSYBX / S&P 2.42% / 10.94% |
LoseSYBX / S&P -100.00% / 4.83% |
LoseSYBX / S&P -98.29% / 10.63% |
| 2025-Q10/3 |
LoseSYBX / S&P -11.43% / -4.27% |
LoseSYBX / S&P -100.00% / 4.98% |
LoseSYBX / S&P -102.58% / 10.57% |
| 2024-Q40/3 |
LoseSYBX / S&P -6.04% / 2.41% |
LoseSYBX / S&P -99.76% / 5.25% |
LoseSYBX / S&P -79.51% / 6.15% |
| 2024-Q31/3 |
LoseSYBX / S&P -0.67% / 5.89% |
WinSYBX / S&P 292.23% / 5.89% |
LoseSYBX / S&P -83.32% / 6.11% |
| 2024-Q21/3 |
LoseSYBX / S&P -16.20% / 4.28% |
WinSYBX / S&P 219.23% / 5.38% |
LoseSYBX / S&P -66.26% / 5.12% |
| 2024-Q11/3 |
LoseSYBX / S&P -53.51% / 10.56% |
WinSYBX / S&P 188.74% / 5.71% |
LoseSYBX / S&P -25.18% / 5.59% |
| 2023-Q43/3 |
WinSYBX / S&P 37.01% / 11.69% |
WinSYBX / S&P 185.68% / 6.81% |
WinSYBX / S&P 22.18% / 7.78% |
| 2023-Q31/3 |
LoseSYBX / S&P -56.43% / -3.27% |
LoseSYBX / S&P -57.50% / 7.52% |
WinSYBX / S&P 192.18% / -5.03% |
| 2023-Q21/3 |
LoseSYBX / S&P -31.96% / 8.74% |
LoseSYBX / S&P -47.85% / 9.50% |
WinSYBX / S&P 1424.18% / -8.57% |
| 2023-Q11/3 |
LoseSYBX / S&P -16.84% / 7.50% |
LoseSYBX / S&P -44.44% / 10.77% |
WinSYBX / S&P 1021.65% / -15.69% |
| 2022-Q40/3 |
LoseSYBX / S&P -20.00% / 7.56% |
LoseSYBX / S&P SYBX unavailable / 11.88% |
LoseSYBX / S&P SYBX unavailable / -17.99% |
| 2022-Q30/3 |
LoseSYBX / S&P -17.39% / -4.88% |
LoseSYBX / S&P SYBX unavailable / 13.47% |
LoseSYBX / S&P SYBX unavailable / -1.41% |
| 2022-Q20/3 |
LoseSYBX / S&P -52.08% / -16.10% |
LoseSYBX / S&P SYBX unavailable / 13.71% |
LoseSYBX / S&P SYBX unavailable / 11.04% |
| 2022-Q11/3 |
WinSYBX / S&P -0.83% / -4.60% |
LoseSYBX / S&P SYBX unavailable / 15.97% |
LoseSYBX / S&P SYBX unavailable / 42.23% |
| 2021-Q40/3 |
LoseSYBX / S&P -20.66% / 11.03% |
LoseSYBX / S&P SYBX unavailable / 15.00% |
LoseSYBX / S&P SYBX unavailable / 96.40% |
| 2021-Q30/3 |
LoseSYBX / S&P -21.59% / 0.58% |
LoseSYBX / S&P SYBX unavailable / 10.77% |
LoseSYBX / S&P SYBX unavailable / 69.42% |
| 2021-Q21/3 |
WinSYBX / S&P 8.66% / 8.55% |
LoseSYBX / S&P SYBX unavailable / 6.58% |
LoseSYBX / S&P SYBX unavailable / 51.81% |
| 2021-Q11/3 |
WinSYBX / S&P 65.74% / 6.17% |
LoseSYBX / S&P SYBX unavailable / -1.06% |
LoseSYBX / S&P SYBX unavailable / 7.39% |
| 2020-Q40/3 |
LoseSYBX / S&P 6.93% / 12.15% |
LoseSYBX / S&P SYBX unavailable / -3.72% |
LoseSYBX / S&P SYBX unavailable / -33.42% |
| 2020-Q30/3 |
LoseSYBX / S&P -0.49% / 8.93% |
LoseSYBX / S&P SYBX unavailable / -2.04% |
LoseSYBX / S&P SYBX unavailable / -27.10% |
| 2020-Q20/3 |
LoseSYBX / S&P 18.02% / 20.54% |
LoseSYBX / S&P -19.96% / -0.46% |
LoseSYBX / S&P SYBX unavailable / -27.11% |
| 2020-Q10/3 |
LoseSYBX / S&P -33.33% / -19.60% |
LoseSYBX / S&P -20.69% / 3.47% |
LoseSYBX / S&P SYBX unavailable / -14.75% |
| 2019-Q41/3 |
WinSYBX / S&P 12.66% / 9.07% |
LoseSYBX / S&P -11.75% / 5.36% |
LoseSYBX / S&P SYBX unavailable / 2.99% |
| 2019-Q30/3 |
LoseSYBX / S&P -74.84% / 1.70% |
LoseSYBX / S&P -56.19% / 5.02% |
LoseSYBX / S&P SYBX unavailable / 0.21% |
| 2019-Q22/3 |
WinSYBX / S&P 19.89% / 4.30% |
WinSYBX / S&P 213.25% / 6.64% |
LoseSYBX / S&P SYBX unavailable / 8.65% |
| 2019-Q10/3 |
LoseSYBX / S&P 8.27% / 13.65% |
LoseSYBX / S&P -6.81% / 8.12% |
LoseSYBX / S&P SYBX unavailable / 14.29% |
| 2018-Q40/3 |
LoseSYBX / S&P -50.67% / -13.52% |
LoseSYBX / S&P 3.11% / 9.05% |
LoseSYBX / S&P SYBX unavailable / 18.23% |
| 2018-Q31/3 |
WinSYBX / S&P 44.56% / 7.71% |
LoseSYBX / S&P 3.11% / 10.21% |
LoseSYBX / S&P SYBX unavailable / 19.06% |
| 2018-Q21/3 |
WinSYBX / S&P 4.80% / 3.43% |
LoseSYBX / S&P -66.04% / 9.03% |
LoseSYBX / S&P SYBX unavailable / 14.46% |
| 2018-Q10/3 |
LoseSYBX / S&P -3.30% / -0.76% |
LoseSYBX / S&P SYBX unavailable / 7.68% |
LoseSYBX / S&P SYBX unavailable / 12.46% |
| 2017-Q40/3 |
LoseSYBX / S&P -48.99% / 6.64% |
LoseSYBX / S&P SYBX unavailable / 7.03% |
LoseSYBX / S&P SYBX unavailable / 13.82% |
| 2017-Q31/3 |
WinSYBX / S&P 62.66% / 4.48% |
LoseSYBX / S&P SYBX unavailable / 5.68% |
LoseSYBX / S&P SYBX unavailable / 17.57% |
| 2017-Q20/3 |
LoseSYBX / S&P -23.74% / 3.09% |
LoseSYBX / S&P SYBX unavailable / 4.83% |
LoseSYBX / S&P SYBX unavailable / 17.74% |
| 2017-Q11/3 |
WinSYBX / S&P 21.67% / 6.07% |
LoseSYBX / S&P SYBX unavailable / 3.67% |
LoseSYBX / S&P SYBX unavailable / 13.32% |
| 2016-Q40/3 |
LoseSYBX / S&P -8.63% / 3.82% |
LoseSYBX / S&P SYBX unavailable / 2.09% |
LoseSYBX / S&P SYBX unavailable / 7.05% |
| 2016-Q30/3 |
LoseSYBX / S&P -53.76% / 3.85% |
LoseSYBX / S&P SYBX unavailable / 0.20% |
LoseSYBX / S&P SYBX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SYBX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -16.34% | 20.78% |
| Annualized return | -16.34% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SYBX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.04% | 83.14% |
| Annualized return | -50.53% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | SYBX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.54% | 319.30% |
| Annualized return | -41.59% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |